Changes and tracking of mammographic density in relation to Pike's model of breast tissue aging

a UK longitudinal study

Valerie A McCormack, Nicholas M Perry, Sarah J Vinnicombe, Isabel Dos Santos Silva

    Research output: Contribution to journalArticle

    28 Citations (Scopus)

    Abstract

    Percent mammographic density (PMD) is a strong marker of breast cancer risk. It may be a correlate of the rate of breast tissue aging, as proposed by Pike to explain breast cancer age-incidence. We examined longitudinal changes in PMD in 645 breast screening attendees in London, UK, in which each had between 2 and 5 screens spanning 3-12 years at ages 50-65 years and compare these to Pike's model. Within-woman PMD declined during these ages, with a slowing rate of decline. Annual rates of decline were 1.4% (95% confidence interval: 1.2-1.6), 0.7% (0.6-0.9) and 0.1% (-0.2 to 0.4) at ages 50, 57 and 64. Dense area declined similarly, but the absolute magnitude of the rate of increase of nondense area was almost double that of dense area. PMD dropped by 2.4% (1.4-3.4) on menopausal transition and increased by 2.4% (1.4-3.5) with the use of hormone therapy. Higher body mass index, greater parity and being Afro-Caribbean or South Asian ethnicities were associated with lower PMD, but did not affect rate of change of PMD at these ages. Within-woman rank correlation of PMD was 0.80 for readings taken 9 years apart. Effects of menopause and parity and the lack of effect of menarche on age-specific PMD at these ages are consistent with the predicted determinants in Pike's model. A high degree of tracking of PMD indicates that at ages 50-65 years high-risk women could be identified by a single early screen at age older than 50.
    Original languageEnglish
    Pages (from-to)452-461
    Number of pages10
    JournalInternational Journal of Cancer
    Volume127
    Issue number2
    DOIs
    Publication statusPublished - 2010

    Fingerprint

    Esocidae
    Longitudinal Studies
    Breast
    Parity
    Breast Neoplasms
    Breast Density
    Menarche
    Menopause
    Reading
    Body Mass Index
    Hormones
    Confidence Intervals

    Cite this

    McCormack, Valerie A ; Perry, Nicholas M ; Vinnicombe, Sarah J ; Dos Santos Silva, Isabel. / Changes and tracking of mammographic density in relation to Pike's model of breast tissue aging : a UK longitudinal study. In: International Journal of Cancer. 2010 ; Vol. 127, No. 2. pp. 452-461.
    @article{b338828a51974e25955a27ea36c3c78f,
    title = "Changes and tracking of mammographic density in relation to Pike's model of breast tissue aging: a UK longitudinal study",
    abstract = "Percent mammographic density (PMD) is a strong marker of breast cancer risk. It may be a correlate of the rate of breast tissue aging, as proposed by Pike to explain breast cancer age-incidence. We examined longitudinal changes in PMD in 645 breast screening attendees in London, UK, in which each had between 2 and 5 screens spanning 3-12 years at ages 50-65 years and compare these to Pike's model. Within-woman PMD declined during these ages, with a slowing rate of decline. Annual rates of decline were 1.4{\%} (95{\%} confidence interval: 1.2-1.6), 0.7{\%} (0.6-0.9) and 0.1{\%} (-0.2 to 0.4) at ages 50, 57 and 64. Dense area declined similarly, but the absolute magnitude of the rate of increase of nondense area was almost double that of dense area. PMD dropped by 2.4{\%} (1.4-3.4) on menopausal transition and increased by 2.4{\%} (1.4-3.5) with the use of hormone therapy. Higher body mass index, greater parity and being Afro-Caribbean or South Asian ethnicities were associated with lower PMD, but did not affect rate of change of PMD at these ages. Within-woman rank correlation of PMD was 0.80 for readings taken 9 years apart. Effects of menopause and parity and the lack of effect of menarche on age-specific PMD at these ages are consistent with the predicted determinants in Pike's model. A high degree of tracking of PMD indicates that at ages 50-65 years high-risk women could be identified by a single early screen at age older than 50.",
    author = "McCormack, {Valerie A} and Perry, {Nicholas M} and Vinnicombe, {Sarah J} and {Dos Santos Silva}, Isabel",
    note = "Copyright 2010 Elsevier B.V., All rights reserved.",
    year = "2010",
    doi = "10.1002/ijc.25053",
    language = "English",
    volume = "127",
    pages = "452--461",
    journal = "International Journal of Cancer",
    issn = "0020-7136",
    publisher = "Wiley",
    number = "2",

    }

    Changes and tracking of mammographic density in relation to Pike's model of breast tissue aging : a UK longitudinal study. / McCormack, Valerie A; Perry, Nicholas M; Vinnicombe, Sarah J; Dos Santos Silva, Isabel.

    In: International Journal of Cancer, Vol. 127, No. 2, 2010, p. 452-461.

    Research output: Contribution to journalArticle

    TY - JOUR

    T1 - Changes and tracking of mammographic density in relation to Pike's model of breast tissue aging

    T2 - a UK longitudinal study

    AU - McCormack, Valerie A

    AU - Perry, Nicholas M

    AU - Vinnicombe, Sarah J

    AU - Dos Santos Silva, Isabel

    N1 - Copyright 2010 Elsevier B.V., All rights reserved.

    PY - 2010

    Y1 - 2010

    N2 - Percent mammographic density (PMD) is a strong marker of breast cancer risk. It may be a correlate of the rate of breast tissue aging, as proposed by Pike to explain breast cancer age-incidence. We examined longitudinal changes in PMD in 645 breast screening attendees in London, UK, in which each had between 2 and 5 screens spanning 3-12 years at ages 50-65 years and compare these to Pike's model. Within-woman PMD declined during these ages, with a slowing rate of decline. Annual rates of decline were 1.4% (95% confidence interval: 1.2-1.6), 0.7% (0.6-0.9) and 0.1% (-0.2 to 0.4) at ages 50, 57 and 64. Dense area declined similarly, but the absolute magnitude of the rate of increase of nondense area was almost double that of dense area. PMD dropped by 2.4% (1.4-3.4) on menopausal transition and increased by 2.4% (1.4-3.5) with the use of hormone therapy. Higher body mass index, greater parity and being Afro-Caribbean or South Asian ethnicities were associated with lower PMD, but did not affect rate of change of PMD at these ages. Within-woman rank correlation of PMD was 0.80 for readings taken 9 years apart. Effects of menopause and parity and the lack of effect of menarche on age-specific PMD at these ages are consistent with the predicted determinants in Pike's model. A high degree of tracking of PMD indicates that at ages 50-65 years high-risk women could be identified by a single early screen at age older than 50.

    AB - Percent mammographic density (PMD) is a strong marker of breast cancer risk. It may be a correlate of the rate of breast tissue aging, as proposed by Pike to explain breast cancer age-incidence. We examined longitudinal changes in PMD in 645 breast screening attendees in London, UK, in which each had between 2 and 5 screens spanning 3-12 years at ages 50-65 years and compare these to Pike's model. Within-woman PMD declined during these ages, with a slowing rate of decline. Annual rates of decline were 1.4% (95% confidence interval: 1.2-1.6), 0.7% (0.6-0.9) and 0.1% (-0.2 to 0.4) at ages 50, 57 and 64. Dense area declined similarly, but the absolute magnitude of the rate of increase of nondense area was almost double that of dense area. PMD dropped by 2.4% (1.4-3.4) on menopausal transition and increased by 2.4% (1.4-3.5) with the use of hormone therapy. Higher body mass index, greater parity and being Afro-Caribbean or South Asian ethnicities were associated with lower PMD, but did not affect rate of change of PMD at these ages. Within-woman rank correlation of PMD was 0.80 for readings taken 9 years apart. Effects of menopause and parity and the lack of effect of menarche on age-specific PMD at these ages are consistent with the predicted determinants in Pike's model. A high degree of tracking of PMD indicates that at ages 50-65 years high-risk women could be identified by a single early screen at age older than 50.

    UR - http://www.scopus.com/inward/record.url?scp=77953706705&partnerID=8YFLogxK

    U2 - 10.1002/ijc.25053

    DO - 10.1002/ijc.25053

    M3 - Article

    VL - 127

    SP - 452

    EP - 461

    JO - International Journal of Cancer

    JF - International Journal of Cancer

    SN - 0020-7136

    IS - 2

    ER -